<p>梅特勒 - 託利多國際（NYSE:MTD - 獲取免費報告）在週一發佈的報告中，摩根大通將其目標股價從 1,413.00 美元下調至 1,200.00 美元。該公司目前對這家醫療儀器供應商的股票給予 “中性” 評級。摩根大通的目標價暗示該股票當前價格有 10.64% 的上漲潛力。</p>
<ul>
<li>Matador 的業績好於預期，但 2026 年的挑戰仍然存在</li>
</ul>
<p>其他幾家股票研究分析師也對該股票發佈了報告。花旗集團將梅特勒 - 託利多國際的目標股價從 1,700.00 美元下調至 1,550.00 美元，並在週五的報告中給予該公司 “買入” 評級。摩根士丹利將梅特勒 - 託利多國際的目標股價從 1,550.00 美元下調至 1,475.00 美元，並在 2 月 10 日的報告中給予該公司 “持平” 評級。傑富瑞金融集團在 3 月 20 日的報告中將梅特勒 - 託利多國際的評級從 “持有” 上調至 “買入”，並將其目標價從 1,400.00 美元上調至 1,450.00 美元。羅伯特·W·貝爾德將梅特勒 - 託利多國際的目標價從 1,445.00 美元下調至 1,194.00 美元，並在週一的報告中給予該公司 “中性” 評級。最後，華爾街 Zen 在 2 月 14 日的報告中將梅特勒 - 託利多國際的評級從 “持有” 上調至 “買入”。七位研究分析師對該股票給予 “買入” 評級，六位分析師給予 “持有” 評級。根據 MarketBeat.com 的數據，梅特勒 - 託利多國際目前的平均評級為 “適度買入”，共識目標價為 1,437.00 美元。</p>
<p><strong>查看我們關於梅特勒 - 託利多國際的最新報告</strong></p>
<h2>梅特勒 - 託利多國際股票表現</h2>
<ul>
<li>3 家中型能源公司分析師認為將晉升至大聯盟</li>
</ul>
<p>週一，NYSE:MTD 的股票下跌 39.84 美元，達到 1,084.62 美元。該公司的股票交易量為 163,567 股，而其平均交易量為 154,988 股。該公司的 50 日簡單移動平均線為 1,276.49 美元，200 日簡單移動平均線為 1,367.66 美元。該公司的市值為 219.6 億美元，市盈率為 25.46，PEG 比率為 2.36，貝塔值為 1.31。梅特勒 - 託利多國際的 52 周低點為 1,087.12 美元，52 周高點為 1,525.17 美元。</p>
<p>梅特勒 - 託利多國際（NYSE:MTD - 獲取免費報告）最後一次發佈財報是在 5 月 7 日，醫療儀器供應商報告該季度每股收益（EPS）為 8.91 美元，超出市場共識預期的 8.70 美元，超出 0.21 美元。該季度的收入為 9.4713 億美元，而分析師預期為 9.4314 億美元。梅特勒 - 託利多國際的淨利潤率為 21.40%，股本回報率為-622.80%。該公司的收入同比增長 7.2%。去年同期，該公司每股收益為 8.19 美元。梅特勒 - 託利多國際已將其 2026 財年的指導目標設定為 46.300-46.950 EPS，2026 年第二季度的指導目標為 10.700-10.850 EPS。平均而言，股票研究分析師預測梅特勒 - 託利多國際在當前財年將發佈 46.54 EPS。</p>
<h2>內部人士下注</h2>
<ul>
<li>根據分析師的説法，5 只高評級股息的上漲潛力達到 50%</li>
</ul>
<p>在其他梅特勒 - 託利多國際的新聞中，首席財務官肖恩·瓦達拉在 2 月 10 日的交易中出售了 800 股該公司的股票。股票以平均價格 1,410.12 美元出售，總交易額為 1,128,096.00 美元。交易後，首席財務官持有 5,288 股公司股票，價值約為 7,456,714.56 美元。這筆交易代表其持股減少了 13.14%。該交易已在向 SEC 提交的文件中披露，文件可在此鏈接查看。內部人士持有該股票的 0.71%。</p>
<h2>機構資金流入和流出</h2>
<p>一些機構投資者最近增加或減少了在該公司的持股。EverSource Wealth Advisors LLC 在第三季度將其在梅特勒 - 託利多國際的持股增加了 2.4%。EverSource Wealth Advisors LLC 目前持有 294 股醫療儀器供應商的股票，價值 361,000 美元，此前在該期間內購買了額外的 7 股。Allworth Financial LP 在第三季度將其在梅特勒 - 託利多國際的持股增加了 6.1%。Allworth Financial LP 目前持有 121 股醫療儀器供應商的股票，價值 149,000 美元，此前在該期間內購買了額外的 7 股。Versant Capital Management Inc 在第三季度將其在梅特勒 - 託利多國際的持股增加了 42.1%。Versant Capital Management Inc 目前持有 27 股醫療儀器供應商的股票，價值 33,000 美元，此前在該期間內購買了額外的 8 股。Valeo Financial Advisors LLC 在第三季度將其在梅特勒 - 託利多國際的持股增加了 4.0%。Valeo Financial Advisors LLC 目前持有 207 股醫療儀器供應商的股票，價值 254,000 美元，此前在該期間內購買了額外的 8 股。最後，Meridian Wealth Management LLC 在第三季度將其在梅特勒 - 託利多國際的持股增加了 1.7%。Meridian Wealth Management LLC 目前持有 480 股醫療儀器供應商的股票，價值 589,000 美元，此前在該期間內購買了額外的 8 股。對沖基金和其他機構投資者持有該公司 95.07% 的股票。</p>
<h2>關於梅特勒 - 託利多國際</h2>
<p>（獲取免費報告）</p>
<p>梅特勒 - 託利多國際公司是一家全球製造和分銷實驗室、工業和食品零售應用精密儀器及服務的公司。公司的產品組合包括實驗室天平和分析儀器、工業稱重系統、過程分析和傳感器、金屬探測和 X 射線檢查設備、檢重秤，以及一系列自動化檢查和數據管理解決方案。梅特勒 - 託利多還提供軟件、校準和生命週期服務，旨在支持客户設施的合規性、質量控制和運營效率。</p>
<p>該公司服務於廣泛的終端市場，包括製藥和生物技術實驗室、化工和食品加工、物流和製造操作，以及對準確稱重和檢查至關重要的零售環境。</p>
<h2>精選故事</h2>
<ul>
<li>五隻我們更看好的股票超過梅特勒 - 託利多國際</li>
<li>在月球基地建成之前，這四家公司獲勝</li>
<li>工業回購：頂級住宅建築供應商引領回購增加</li>
<li>如果通脹意外下行，這三隻股票將獲利</li>
<li>MercadoLibre 大膽投資於增長：折扣加深</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1URA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1URA"/></p>
<p><em>此即時新聞提醒由敍述科學技術和來自 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資 1000 美元在梅特勒 - 託利多國際嗎？</h2>
<p>在考慮梅特勒 - 託利多國際之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而梅特勒 - 託利多國際並不在名單上。</p>
<p>雖然梅特勒 - 託利多國際目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

梅特勒-託利多

摩根大通

<p>摩根大通已將梅特勒 - 託利多國際（NYSE:MTD）的目標股價從 1,413.00 美元下調至 1,200.00 美元，維持 “中性” 評級。這表明與當前股價相比，潛在上漲幅度為 10.64%。其他分析師也調整了他們的評級，花旗集團設定的目標為 1,550.00 美元，摩根士丹利為 1,475.00 美元。梅特勒 - 託利多的股票最近交易價格為 1,084.62 美元，市值為 219.6 億美元，市盈率為 25.46。該公司報告每股收益為 8.91 美元，超出預期</p>

<p>Mettler-Toledo International (NYSE:MTD - Get Free Report) had its price target decreased by analysts at JPMorgan Chase &amp; Co. from $1,413.00 to $1,200.00 in a report issued on Monday,Benzinga reports. The firm currently has a &#34;neutral&#34; rating on the medical instruments supplier's stock. JPMorgan Chase &amp; Co.'s price objective suggests a potential upside of 10.64% from the stock's current price.</p>
<div class="lb-trans"><p>梅特勒 - 託利多國際（NYSE:MTD - 獲取免費報告）在週一發佈的報告中，摩根大通將其目標股價從 1,413.00 美元下調至 1,200.00 美元。該公司目前對這家醫療儀器供應商的股票給予 “中性” 評級。摩根大通的目標價暗示該股票當前價格有 10.64% 的上漲潛力。</p>
</div><ul>
<li>Matador’s Results Were Better Than Feared, But 2026 Headwinds Still Matter</li>
</ul>
<div class="lb-trans"><ul>
<li>Matador 的業績好於預期，但 2026 年的挑戰仍然存在</li>
</ul>
</div><p>Several other equities research analysts have also issued reports on the stock. Citigroup lowered their target price on shares of Mettler-Toledo International from $1,700.00 to $1,550.00 and set a &#34;buy&#34; rating for the company in a report on Friday. Morgan Stanley lowered their target price on shares of Mettler-Toledo International from $1,550.00 to $1,475.00 and set an &#34;equal weight&#34; rating for the company in a report on Tuesday, February 10th. Jefferies Financial Group upgraded shares of Mettler-Toledo International from a &#34;hold&#34; rating to a &#34;buy&#34; rating and lifted their price objective for the company from $1,400.00 to $1,450.00 in a report on Friday, March 20th. Robert W. Baird decreased their price objective on shares of Mettler-Toledo International from $1,445.00 to $1,194.00 and set a &#34;neutral&#34; rating for the company in a report on Monday. Finally, Wall Street Zen upgraded shares of Mettler-Toledo International from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a report on Saturday, February 14th. Seven research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, Mettler-Toledo International presently has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $1,437.00.</p>
<div class="lb-trans"><p>其他幾家股票研究分析師也對該股票發佈了報告。花旗集團將梅特勒 - 託利多國際的目標股價從 1,700.00 美元下調至 1,550.00 美元，並在週五的報告中給予該公司 “買入” 評級。摩根士丹利將梅特勒 - 託利多國際的目標股價從 1,550.00 美元下調至 1,475.00 美元，並在 2 月 10 日的報告中給予該公司 “持平” 評級。傑富瑞金融集團在 3 月 20 日的報告中將梅特勒 - 託利多國際的評級從 “持有” 上調至 “買入”，並將其目標價從 1,400.00 美元上調至 1,450.00 美元。羅伯特·W·貝爾德將梅特勒 - 託利多國際的目標價從 1,445.00 美元下調至 1,194.00 美元，並在週一的報告中給予該公司 “中性” 評級。最後，華爾街 Zen 在 2 月 14 日的報告中將梅特勒 - 託利多國際的評級從 “持有” 上調至 “買入”。七位研究分析師對該股票給予 “買入” 評級，六位分析師給予 “持有” 評級。根據 MarketBeat.com 的數據，梅特勒 - 託利多國際目前的平均評級為 “適度買入”，共識目標價為 1,437.00 美元。</p>
</div><p><strong>View Our Latest Report on Mettler-Toledo International</strong></p>
<div class="lb-trans"><p><strong>查看我們關於梅特勒 - 託利多國際的最新報告</strong></p>
</div><h2>Mettler-Toledo International Stock Performance</h2>
<div class="lb-trans"><h2>梅特勒 - 託利多國際股票表現</h2>
</div><ul>
<li>3 Mid-Cap Energy Firms Analysts See Moving Up to the Big Leagues</li>
</ul>
<div class="lb-trans"><ul>
<li>3 家中型能源公司分析師認為將晉升至大聯盟</li>
</ul>
</div><p>Shares of NYSE:MTD traded down $39.84 on Monday, reaching $1,084.62. The company's stock had a trading volume of 163,567 shares, compared to its average volume of 154,988. The company has a 50-day simple moving average of $1,276.49 and a 200 day simple moving average of $1,367.66. The company has a market cap of $21.96 billion, a P/E ratio of 25.46, a PEG ratio of 2.36 and a beta of 1.31. Mettler-Toledo International has a 52-week low of $1,087.12 and a 52-week high of $1,525.17.</p>
<div class="lb-trans"><p>週一，NYSE:MTD 的股票下跌 39.84 美元，達到 1,084.62 美元。該公司的股票交易量為 163,567 股，而其平均交易量為 154,988 股。該公司的 50 日簡單移動平均線為 1,276.49 美元，200 日簡單移動平均線為 1,367.66 美元。該公司的市值為 219.6 億美元，市盈率為 25.46，PEG 比率為 2.36，貝塔值為 1.31。梅特勒 - 託利多國際的 52 周低點為 1,087.12 美元，52 周高點為 1,525.17 美元。</p>
</div><p>Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its earnings results on Thursday, May 7th. The medical instruments supplier reported $8.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $8.70 by $0.21. The firm had revenue of $947.13 million during the quarter, compared to analyst estimates of $943.14 million. Mettler-Toledo International had a net margin of 21.40% and a negative return on equity of 622.80%. The business's revenue was up 7.2% on a year-over-year basis. During the same quarter last year, the business earned $8.19 EPS. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. On average, equities research analysts forecast that Mettler-Toledo International will post 46.54 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>梅特勒 - 託利多國際（NYSE:MTD - 獲取免費報告）最後一次發佈財報是在 5 月 7 日，醫療儀器供應商報告該季度每股收益（EPS）為 8.91 美元，超出市場共識預期的 8.70 美元，超出 0.21 美元。該季度的收入為 9.4713 億美元，而分析師預期為 9.4314 億美元。梅特勒 - 託利多國際的淨利潤率為 21.40%，股本回報率為-622.80%。該公司的收入同比增長 7.2%。去年同期，該公司每股收益為 8.19 美元。梅特勒 - 託利多國際已將其 2026 財年的指導目標設定為 46.300-46.950 EPS，2026 年第二季度的指導目標為 10.700-10.850 EPS。平均而言，股票研究分析師預測梅特勒 - 託利多國際在當前財年將發佈 46.54 EPS。</p>
</div><h2>Insiders Place Their Bets</h2>
<div class="lb-trans"><h2>內部人士下注</h2>
</div><ul>
<li>5 Highly Rated Dividends With 50% Upside According to Analysts</li>
</ul>
<div class="lb-trans"><ul>
<li>根據分析師的説法，5 只高評級股息的上漲潛力達到 50%</li>
</ul>
</div><p>In other Mettler-Toledo International news, CFO Shawn Vadala sold 800 shares of the firm's stock in a transaction dated Tuesday, February 10th. The shares were sold at an average price of $1,410.12, for a total transaction of $1,128,096.00. Following the transaction, the chief financial officer owned 5,288 shares of the company's stock, valued at approximately $7,456,714.56. This trade represents a 13.14% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.71% of the stock is owned by insiders.</p>
<div class="lb-trans"><p>在其他梅特勒 - 託利多國際的新聞中，首席財務官肖恩·瓦達拉在 2 月 10 日的交易中出售了 800 股該公司的股票。股票以平均價格 1,410.12 美元出售，總交易額為 1,128,096.00 美元。交易後，首席財務官持有 5,288 股公司股票，價值約為 7,456,714.56 美元。這筆交易代表其持股減少了 13.14%。該交易已在向 SEC 提交的文件中披露，文件可在此鏈接查看。內部人士持有該股票的 0.71%。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>機構資金流入和流出</h2>
</div><p>A number of institutional investors have recently added to or reduced their stakes in the business. EverSource Wealth Advisors LLC increased its position in Mettler-Toledo International by 2.4% during the 3rd quarter. EverSource Wealth Advisors LLC now owns 294 shares of the medical instruments supplier's stock valued at $361,000 after purchasing an additional 7 shares during the period. Allworth Financial LP increased its position in Mettler-Toledo International by 6.1% during the 3rd quarter. Allworth Financial LP now owns 121 shares of the medical instruments supplier's stock valued at $149,000 after purchasing an additional 7 shares during the period. Versant Capital Management Inc increased its position in Mettler-Toledo International by 42.1% during the 3rd quarter. Versant Capital Management Inc now owns 27 shares of the medical instruments supplier's stock valued at $33,000 after purchasing an additional 8 shares during the period. Valeo Financial Advisors LLC increased its position in Mettler-Toledo International by 4.0% during the 3rd quarter. Valeo Financial Advisors LLC now owns 207 shares of the medical instruments supplier's stock valued at $254,000 after purchasing an additional 8 shares during the period. Finally, Meridian Wealth Management LLC increased its position in Mettler-Toledo International by 1.7% during the 3rd quarter. Meridian Wealth Management LLC now owns 480 shares of the medical instruments supplier's stock valued at $589,000 after purchasing an additional 8 shares during the period. Hedge funds and other institutional investors own 95.07% of the company's stock.</p>
<div class="lb-trans"><p>一些機構投資者最近增加或減少了在該公司的持股。EverSource Wealth Advisors LLC 在第三季度將其在梅特勒 - 託利多國際的持股增加了 2.4%。EverSource Wealth Advisors LLC 目前持有 294 股醫療儀器供應商的股票，價值 361,000 美元，此前在該期間內購買了額外的 7 股。Allworth Financial LP 在第三季度將其在梅特勒 - 託利多國際的持股增加了 6.1%。Allworth Financial LP 目前持有 121 股醫療儀器供應商的股票，價值 149,000 美元，此前在該期間內購買了額外的 7 股。Versant Capital Management Inc 在第三季度將其在梅特勒 - 託利多國際的持股增加了 42.1%。Versant Capital Management Inc 目前持有 27 股醫療儀器供應商的股票，價值 33,000 美元，此前在該期間內購買了額外的 8 股。Valeo Financial Advisors LLC 在第三季度將其在梅特勒 - 託利多國際的持股增加了 4.0%。Valeo Financial Advisors LLC 目前持有 207 股醫療儀器供應商的股票，價值 254,000 美元，此前在該期間內購買了額外的 8 股。最後，Meridian Wealth Management LLC 在第三季度將其在梅特勒 - 託利多國際的持股增加了 1.7%。Meridian Wealth Management LLC 目前持有 480 股醫療儀器供應商的股票，價值 589,000 美元，此前在該期間內購買了額外的 8 股。對沖基金和其他機構投資者持有該公司 95.07% 的股票。</p>
</div><h2>About Mettler-Toledo International</h2>
<div class="lb-trans"><h2>關於梅特勒 - 託利多國際</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company's product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.</p>
<div class="lb-trans"><p>梅特勒 - 託利多國際公司是一家全球製造和分銷實驗室、工業和食品零售應用精密儀器及服務的公司。公司的產品組合包括實驗室天平和分析儀器、工業稱重系統、過程分析和傳感器、金屬探測和 X 射線檢查設備、檢重秤，以及一系列自動化檢查和數據管理解決方案。梅特勒 - 託利多還提供軟件、校準和生命週期服務，旨在支持客户設施的合規性、質量控制和運營效率。</p>
</div><p>The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.</p>
<div class="lb-trans"><p>該公司服務於廣泛的終端市場，包括製藥和生物技術實驗室、化工和食品加工、物流和製造操作，以及對準確稱重和檢查至關重要的零售環境。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精選故事</h2>
</div><ul>
<li>Five stocks we like better than Mettler-Toledo International</li>
<li>Before the Moon Base Gets Built, These 4 Companies Win</li>
<li>Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases</li>
<li>3 Stocks That Win If Inflation Surprises to the Downside</li>
<li>MercadoLibre Boldly Invests in Growth: Discount Deepens</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票超過梅特勒 - 託利多國際</li>
<li>在月球基地建成之前，這四家公司獲勝</li>
<li>工業回購：頂級住宅建築供應商引領回購增加</li>
<li>如果通脹意外下行，這三隻股票將獲利</li>
<li>MercadoLibre 大膽投資於增長：折扣加深</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1URA" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&amp;Symbol=MTD"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和來自 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Mettler-Toledo International Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1000 美元在梅特勒 - 託利多國際嗎？</h2>
</div><p>Before you consider Mettler-Toledo International, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮梅特勒 - 託利多國際之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mettler-Toledo International wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而梅特勒 - 託利多國際並不在名單上。</p>
</div><p>While Mettler-Toledo International currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然梅特勒 - 託利多國際目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

JPMorgan Chase & Co. Issues Pessimistic Forecast for Mettler-Toledo International (NYSE:MTD) Stock Price

Market Beat

花旗

摩根士丹利

Jefferies Financial

Matador資源

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

CITIGROUP INC 6.250 NON CUM SER II PFD WI

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

摩根大通對梅特勒 - 託利多國際公司（NYSE: MTD）的股價發佈了悲觀的預測